These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32819616)

  • 1. Erratum to: Pollack A, Chinea FM, Bossart E, Kwon D, Abramowitz MC, Lynne C, Jorda M, Marples B, Patel VN, Wu XD, Reis I, Studenski MT, Casillas J, Stoyanova R. Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy. Int J Radiat Oncol Biol Phys 2020;107:305-315.
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):328. PubMed ID: 32819616
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to: Dawei Chen, Vivek Verma, Roshal R. Patel, et al. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials. Int J Radiat Oncol Biol Phys 2020:108(1);196-203.
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):623. PubMed ID: 33989592
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to "Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600).
    Song CW; Levitt SH; Park H
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1193; author reply 1193-4. PubMed ID: 22036162
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to: Schreibmann E, Schuster D, Rossi P, et al. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. Int J Radiat Oncol Biol Phys 2016;96:206-213.
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):231. PubMed ID: 30102199
    [No Abstract]   [Full Text] [Related]  

  • 5. Erratum to: Wilkins AC, Gusterson B, Szijgyarto Z, et al. Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2018;101:309-315.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967236
    [No Abstract]   [Full Text] [Related]  

  • 6. Erratum to: Jones, CU; Pugh, SL; Sandler, HM; Chetner, MP; Amin, MB; Bruner, DW; Zietman, AL; Den, RB; Leibenhaut, MH; Longo, JM; Bahary, JP; Rosenthal, SA; Souhami, L; Michalski, JM; Hartford, AC; Amin, PP; Roach, M 3rd; Yee, D; Efstathiou, JA; Rodgers, JP; Feng, FY; Shipley, WU. Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial. Int J Radiat Oncol Biol Phys 2022;112:294-303. doi: 10.1016/j.ijrobp.2021.08.031.
    Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):265. PubMed ID: 36526397
    [No Abstract]   [Full Text] [Related]  

  • 7. Erratum to: Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)  Int J Radiat Oncol Biol Phys 2020;108:1399-1400.
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):698. PubMed ID: 37270256
    [No Abstract]   [Full Text] [Related]  

  • 8. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 9. Erratum to: Hafeez S, McDonald F, Lalondrelle S, et al. Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment. Int J Radiat Oncol Biol Phys 2017;98:115-122.
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):532-533. PubMed ID: 29353666
    [No Abstract]   [Full Text] [Related]  

  • 10. Erratum to: Britton B, Baker AL, Wolfenden L, Wratten C, Bauer J, Beck AK, McCarter K, Harrowfield J, Isenring E, Tang C, Oldmeadow C, and Carter G. Eating As Treatment (EAT): A Stepped-Wedge, Randomized Controlled Trial of a Health Behavior Change Intervention Provided by Dietitians to Improve Nutrition in Patients With Head and Neck Cancer Undergoing Radiation Therapy (TROG 12.03). Int J Radiat Oncol Biol Phys 2019.
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):606. PubMed ID: 32531393
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum to: Ho AY, Olm-Shipman M, Zhang Z, et al. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation. Int J Radiat Oncol Biol Phys 2018;101;325-333.
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):231. PubMed ID: 30102200
    [No Abstract]   [Full Text] [Related]  

  • 12. Erratum to: van der Velden JM, Peters M, Verlaan J-J, Versteeg AL, Zhang L, Tsao M, Danjoux C, Barnes E, van Vulpen M, Chow E, Verkooijen HM. Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases. Int J Radiat Oncol Biol Phys 2017;99:859-866.
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1186. PubMed ID: 31327423
    [No Abstract]   [Full Text] [Related]  

  • 13. Erratum to Ringash J, Fisher R, Peters L, et al. Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: a substudy of randomized trial trans-Tasman radiation oncology group (TROG) 02.02 (HeadSTART). Int J Radiat Oncol Biol Phys 2017;97:678-686.
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):244. PubMed ID: 28816156
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum to: Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG II, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys 2020;106:255-260.
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1111. PubMed ID: 32171455
    [No Abstract]   [Full Text] [Related]  

  • 15. Erratum to: Reddy J, Lei X, Bloom S, et al. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2024;115(3): 629-644.
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1034. PubMed ID: 38851265
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratum to: DR, Owen; PS, Boonstra; BL, Viglianti; J, Balter; MJ, Schipper; W, Jackson; I El, Naqa; S, Jolly; R Ten, Haken; FM, Kong; MM, Matuszak. Modeling Patient-Specific Dose-Function Response Using Perfusion SPECT/CT for Enhanced Characterization of Personalized Functional Changes. Int J Radiat Oncol Biol Phys 2018;102(4):1265-1275.
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1552. PubMed ID: 34273334
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
    Russi EG; Numico G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Nguyen PL. Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2016;94:975-977.
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1549. PubMed ID: 27479731
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138-1142.
    ; Fields EC; Erickson B; Hubbard A; Chino J; Small C; Weiner A; Petereit D; Mayadev JS; Yashar CM; Joyner M
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):869. PubMed ID: 38340775
    [No Abstract]   [Full Text] [Related]  

  • 20. Erratum to: Xiaoyu Li, Youling Gong, Dan Li, et al. Low-Dose Radiation Therapy Promotes Radiation Pneumonitis by Activating NLRP3 Inflammasome. Int J Radiat Oncol Biol Phys 2020;107(4):804-814.
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):837. PubMed ID: 33516446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.